(Q51126781)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Daniel C Chambers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Debra Enever

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Nina Ilic

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Lisa Sparks

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Kylie Whitelaw

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

John Ayres

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Dalia Khalil

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Kerry M Atkinson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Peter M A Hopkins

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

9 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

1013-1018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Lung fibrosis, premature graying, and macrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Mesenchymal stem cells and the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Type 2 alveolar cells are stem cells in adult lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Injured microenvironment directly guides the differentiation of engrafted Flk-1(+) mesenchymal stem cell in lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Cell therapy trials for lung diseases: progress and cautions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Manufacture of clinical grade human placenta-derived multipotent mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Therapeutic applications of mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12343

21 January 2018

Identifiers

DOI

10.1111/RESP.12343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25039426%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference